PISTELLI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 6.980
AS - Asia 4.515
EU - Europa 4.400
SA - Sud America 750
AF - Africa 416
OC - Oceania 43
Continente sconosciuto - Info sul continente non disponibili 2
Totale 17.106
Nazione #
US - Stati Uniti d'America 6.785
IT - Italia 2.146
SG - Singapore 1.320
CN - Cina 1.111
HK - Hong Kong 1.086
BR - Brasile 637
SE - Svezia 492
BG - Bulgaria 342
DE - Germania 334
IN - India 251
GB - Regno Unito 221
CI - Costa d'Avorio 217
RU - Federazione Russa 199
TR - Turchia 183
FI - Finlandia 140
NL - Olanda 126
VN - Vietnam 115
FR - Francia 103
CA - Canada 102
AT - Austria 94
BD - Bangladesh 54
SN - Senegal 37
AU - Australia 35
IQ - Iraq 35
JP - Giappone 35
KR - Corea 35
NG - Nigeria 35
PK - Pakistan 35
SA - Arabia Saudita 34
MX - Messico 33
UA - Ucraina 33
AR - Argentina 28
PL - Polonia 27
ID - Indonesia 26
VE - Venezuela 24
ZA - Sudafrica 23
CO - Colombia 22
PH - Filippine 21
TN - Tunisia 21
IE - Irlanda 20
UZ - Uzbekistan 20
TT - Trinidad e Tobago 18
CH - Svizzera 17
AE - Emirati Arabi Uniti 16
MA - Marocco 16
MY - Malesia 16
ES - Italia 15
BE - Belgio 14
IR - Iran 13
BJ - Benin 12
IL - Israele 12
TH - Thailandia 11
EG - Egitto 10
HU - Ungheria 10
JO - Giordania 10
KE - Kenya 10
NP - Nepal 10
TW - Taiwan 10
CZ - Repubblica Ceca 9
GR - Grecia 9
UY - Uruguay 9
JM - Giamaica 8
DK - Danimarca 7
EC - Ecuador 7
KZ - Kazakistan 7
LB - Libano 7
NZ - Nuova Zelanda 7
PE - Perù 7
PT - Portogallo 7
BB - Barbados 6
ET - Etiopia 6
PY - Paraguay 6
AL - Albania 5
AZ - Azerbaigian 5
BH - Bahrain 5
CL - Cile 5
CR - Costa Rica 5
NO - Norvegia 5
TZ - Tanzania 5
AM - Armenia 4
DO - Repubblica Dominicana 4
DZ - Algeria 4
LI - Liechtenstein 4
LK - Sri Lanka 4
LT - Lituania 4
PA - Panama 4
RO - Romania 4
BO - Bolivia 3
CY - Cipro 3
HN - Honduras 3
KH - Cambogia 3
KW - Kuwait 3
LU - Lussemburgo 3
MG - Madagascar 3
OM - Oman 3
RW - Ruanda 3
SC - Seychelles 3
AG - Antigua e Barbuda 2
BZ - Belize 2
GE - Georgia 2
Totale 17.062
Città #
Hong Kong 1.075
Ashburn 1.012
Singapore 623
Santa Clara 591
Shanghai 490
Fairfield 478
Woodbridge 412
Chandler 372
Sofia 342
New York 329
Boardman 289
Houston 280
Florence 271
Ann Arbor 258
Princeton 247
Seattle 241
Wilmington 228
Abidjan 217
Beijing 217
Lawrence 213
Milan 185
Pisa 181
Cambridge 176
Medford 150
Istanbul 122
Munich 116
Rome 105
Los Angeles 90
Frankfurt am Main 77
Vienna 74
San Diego 72
Hefei 70
Ogden 67
Ottawa 64
Des Moines 52
Nanjing 51
London 48
Turku 46
Serra 44
Genoa 41
Dakar 37
São Paulo 34
Bremen 33
Chicago 32
Pune 32
Belo Horizonte 31
Livorno 31
Lucca 30
Nuremberg 30
Dong Ket 29
Düsseldorf 29
Tokyo 29
Dearborn 28
Redwood City 27
Jacksonville 26
Lancaster 26
Turin 26
Bologna 24
Naples 24
Izmir 23
Seoul 23
Warsaw 21
Bari 20
Fuzhou 20
Rio de Janeiro 20
Cascina 19
Bengaluru 18
Helsinki 18
Mysore 18
Palermo 18
Dublin 17
Hyderabad 17
Norwalk 17
San Francisco 17
Lappeenranta 16
Tashkent 16
Kunming 15
Pontedera 15
Amsterdam 14
Bobigny 14
Boulder 14
Dhaka 14
Vicopisano 14
Karachi 13
Nanchang 13
Tunis 13
Cotonou 12
Dallas 12
Hubli 12
Mumbai 12
Washington 12
Dubai 11
Guangzhou 11
Lagos 11
Melbourne 11
Padova 11
Patna 11
Pescara 11
Prato 11
Riyadh 11
Totale 11.190
Nome #
Diminishing benefits of urban living for children and adolescents' growth and development 235
Coagulation and fibrinolytic system impairment in insulin-dependent diabetes mellitus 228
Usefulness of a compendium of respiratory standard questionnaires for adults (CORSQ) 214
Epidemiologia ed effetti sulla salute del fumo di tabacco 202
Percorso di follow-up clinico, funzionale e radiologico dei pazienti dimessi con diagnosi di COVID-19 dall’Azienda Ospedaliero-Universitaria Pisana (AOUP) - Metodologia e arruolamento preliminare 186
Appendix 3: Compendium of respiratory standard questionnaires for adults (CORSQ) 169
Inclusion of peak expiratory flow for selection of the 'best' forced vital capacity manoeuvre 166
A narrative review of epidemiology and prevention of lung cancer: sex/gender differences? 165
Epidemiologia della broncopneumopatia cronico-ostruttiva: fattori di rischio ambientali ed occupazionali [Epidemiology of the chronic obstructive pulmonary disease: Environmental and occupational risk factors] 161
Standardized Clinical, Functional, and Radiological Pulmonary Follow-Up in Patients Discharged with Diagnosis of COVID-19 From an Italian Hospital - Preliminary Data 158
Impact of long-term exposure to cigarette smoking on skin microvascular function 146
Screen-detected multiple primary lung cancers in the ITALUNG trial 145
Integrated environmental and clinical surveillance of viral acute respiratory infections in close communities: opportunities and challenges 145
C-C motive chemokine ligand 2 and thromboinflammation in COVID-19-associated pneumonia: A retrospective study 144
Definition, epidemiology and natural history of COPD 141
Basi fisiopatologiche, diagnosi e trattamento del tabagismo 140
Mortality, survival and incidence rates in the ITALUNG randomised lung cancer screening trial 138
Smooth reference equations for slow vital capacity and flow-volume curve indexes 137
Multimodal lung cancer screening using the ITALUNG Biomarker Panel and Low Dose Computed Tomography. Results of the ITALUNG biomarker study 132
Smoking Cessation in the ITALUNG Lung Cancer Screening: what does “teachable moment” mean? 130
L'epidemiologia della broncopneumopatia cronica ostruttiva 130
Life gain in Italian smokers who quit 128
COPD symptoms/diagnoses and work exposure: a 20 years population-based survey 128
Respiratory symptoms/diseases, impaired lung function, and drug use in two Italian general population samples 128
Respiratory symptoms/diseases prevalence is still increasing: A 25-yr population study 128
Questionnaires, spirometry and PEF monitoring in epidemiological studies on elderly respiratory patients 128
Venous Thromboembolism in Cancer: Frequently Asked Questions When Guidelines are Inconclusive 127
Reference equations for spirometry from a general population sample in central Italy 125
Prescriptive adherence to GINA guidelines and asthma control: An Italian cross sectional study in general practice 125
Utilità dei complessi Trombina-Antitrombina nella diagnosi di embolia polmonare 124
RItA: The Italian severe/uncontrolled asthma registry 124
Integrated environmental and clinical surveillance for the prevention of acute respiratory infections in closed settings and vulnerable communities: school, prison and nursing home (Stell-ARI Project) 121
Efficacy of intravenous immunoglobulin therapy in a case of autoimmune-mediated chronic active hepatitis 121
18-yr cumulative incidence of respiratory/allergic symptoms/diseases and risk factors in the Pisa epidemiological study 121
Patterns of Long COVID Symptoms: A Multi-Center Cross Sectional Study 121
Fumo di sigaretta in gravidanza: studio osservazionale prospettico in tre città della Toscana [Cigarette smoking in pregnancy: observational prospective study in three towns of Tuscany Region (Central Italy)] 120
Depressive, anxious, withdrawal symptoms, and craving as possible predictors of abstinence maintenance in smokers attending a 12-week quitting program 120
Percentiles of Inspiratory Capacity in Healthy Nonsmokers: A Pilot Study 120
COPD management according to old and new GOLD guidelines: An observational study with Italian general practitioners 119
Reduction of risk of dying from tobacco-related diseases after quitting smoking in Italy 115
Molecular profile in body fluids in subjects enrolled in a randomised trial for lung cancer screening: Perspectives of integrated strategies for early diagnosis 114
Nicotine dependence and psychological distress: outcomes and clinical implications in smoking cessation 114
Decreased cardiovascular mortality in the ITALUNG lung cancer screening trial: Analysis of underlying factors 114
Weight gain after smoking cessation 113
Urban residence is associated with bronchial hyper-responsiveness in Italian general population samples 113
Changes in obesity status and lung function decline in a general population sample 111
Multy-symptom asthma (msa) as indication of healthcare utilization burden (hub) in a cohort of Italian young asthmatic subjects 110
ARDS da prolasso mitralico acuto in assuntore di cocaina 109
European randomized lung cancer screening trials: Post NLST 108
Family history for chronic lung diseases and epidemiological determinants of COPD in three European countries 108
Cessazione del fumo di sigarette di tabacco in individui resistenti alle terapie tradizionali; uno studio pilota di intervento mindfulness-based 105
Respiratory symptoms/diseases and lifetime cumulative exposure to environmental tobacco smoke (ETS) in never smoker Italian women (SEASD Study) 105
Integrating the care of the complex COPD patient 105
Variation of obstructive severity in an Italian general population sample surveyed 18 years apart 104
null 103
null 103
I centri antifumo in Italia e il progetto 6elle 102
Prescriptive appropriateness using the new GOLD guidelines in the COMODHES study with Italian general practitioners 98
Eroina e asma bronchiale 98
null 96
Four-year results of low-dose CT screening and nodule management in the ITALUNG trial 96
Investigating Promising Point-of-Care Diagnostics in Pleural Effusion: Assessment of Bedside Glucometer Accuracy for Pleural Fluid Glucose Versus Standard Laboratory and Blood Gas Analyser Methods 96
Abitudini al fumo e sintomi/diagnosi di BPCO in un campione di popolazione generale monitorato per 25 anni 93
Esperienza di un intervento condotto da fisioterapista respiratorio e infermiere per favorire la cessazione del fumo in pazienti degenti in un reparto di Pneumologia 93
Design, recruitment and baseline results of the ITALUNG trial for lung cancer screening with low-dose CT 93
L’attività dei Centri Antifumo italiani tra problematiche e aree da potenziare: i risultati di un’indagine svolta attraverso un questionario on-line 92
Moderate-severe coronary calcification predicts long-term cardiovascular death in CT lung cancer screening: The ITALUNG trial 90
Five-year follow-up of pulmonary embolism under anticoaugulation: The PISA-PEET (Pulmonary Embolism Extension Therapy) study 88
Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: A comparative risk assessment 87
Mortalità per malattie respiratorie in Italia (1990-2010). Parte II: Tassi standardizzati, confronto con l’Europa e conclusioni. 86
Overlap delle malattie respiratorie: fenotipi eosinofilici in un campione italiano di popolazione generale 86
Electronic cigarette use among Italian smokers: patterns, settings, and adverse events 85
Prevalence of airways obstruction in a general population: European Respiratory Society vs American Thoracic Society definition 84
Volume di prestazioni erogate dai Centri antifuno italiani e loro caratetristiche predittive di successo nei tentativi per smettere effettuati dai fumatori afferenti 84
Valori di riferimento e standardizzazione dei referti 83
Eosinophilic phenotypes of overlapping respiratory diseases in an Italian general population sample 83
Smoking reduction in smokers compliant to a smoking cessation trial with nicotine patch 82
Multi-symptom asthma (MSA) and comorbidities in a cohort of Italian young asthmatic subjects 82
Mortalità per malattie respiratorie in Italia (1990-2010). Parte I: Metodi e tassi grezzi nazionali e per regione 82
PLASMA/SALIVA AND GENOTYPIC/PHENOTYPIC DIFFERENCES OF NICOTINE METABOLITE RATIO 80
Comparison of lung function in the Italian and Swedish population samples 79
The Global Cardiovascular Risk Transition: Associations of Four Metabolic Risk Factors with National Income, Urbanization, and Western Diet in 1980 and 2008 79
Covid-19 and the role of smoking: The protocol of the multicentric prospective study COSMO-IT (covid19 and smoking in italy) 78
Thoracic Ultrasound for Pre-Procedural Dynamic Assessment of Non-Expandable Lung: A Non-Invasive, Real-Time and Multifaceted Diagnostic Tool 77
Long-term lung ultrasound follow-up in patients after COVID-19 pneumonia hospitalization: A prospective comparative study with chest computed tomography 77
Short term longitudinal evaluation of smoking-related emphysema: analisys from Italung-CT Study 77
Pharmacotherapy for smoking cessation 76
Nicotine dependence, psychological distress and personality traits as possible predictors of smoking cessation 72
Atopy as a predictor of allergic respiratory diseases in an Italian general population sample 71
Screening per il cancro del polmone con tomografia computerizzata (CT scan) a bassa dose: studio controllato randomizzato Italung-CT. Stato di avanzamento del progetto. Risultati al 30.06.2008. 71
Relazione tra profilo metabolico della nicotina e caratteristiche demografiche, cliniche e di abitudine al fumo. Risultati preliminari nella vita reale 70
Negative affectivity and nicotine withdrawal during smoking cessation 69
Tobacco smoking: why physicians do not make diagnosis? 69
Fattori individuali e ambientali di rischio respiratorio in soggetti vulnerabili che vivono in comunità chiuse (RSA e carcere): dati preliminari dello studio StellARI 68
Characteristics of smokers according to their Nicotine Metabolite Ratio, preliminary results from a real-life experience 68
Nicotine Metabolite Ratio in Smokers: A Real World Experience 68
Lung function in a group of smokers or ex smokers enrolled in a randomized controlled trial (RCT) with low-dose computer tomography (CT) for lung cancer screening (ITALUNG-CT study) 68
Asthma control in real life: ARGA (Respiratory allergic diseases: monitoring study of GINA and ARIA guidelines) project 65
Funzione respiratoria in un gruppo di soggetti a rischio arruolati nel braccio attivo di uno studio randomizzato controllato di screening del tumore polmonare con TC a basso dosaggio (Italung-CT) 65
Pirfenidone for Idiopathic Pulmonary Fibrosis and Beyond 65
Totale 11.065
Categoria #
all - tutte 67.770
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 67.770


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202027 0 0 0 0 0 0 0 0 0 0 0 27
2020/2021691 31 32 34 16 41 19 32 83 92 68 91 152
2021/20222.023 34 70 27 59 339 322 224 75 128 50 169 526
2022/20232.088 346 180 160 133 166 215 40 117 475 21 150 85
2023/20242.227 134 151 204 120 281 478 122 170 69 75 133 290
2024/20258.141 223 335 174 402 561 536 732 444 958 1.186 807 1.783
Totale 17.742